Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the ABLE Exoskeleton [NA]
A clinical investigation is evaluating the safety and performance of integrating Functional Electrical Stimulation with the ABLE Exoskeleton…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
A National Institute of Allergy and Infectious Diseases-sponsored clinical study is currently recruiting, aiming to conduct comprehensive mu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) [Phase 2]
A Phase 2 trial evaluating RO7268489 as add-on therapy to ocrelizumab in participants with progressive multiple sclerosis is currently recru…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Exercise Training for People With Advanced Multiple Sclerosis [NA]
Clinical trial update for an exercise training study in people with advanced multiple sclerosis, sponsored by the University of Ottawa; the …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Caregiver Burden in Caregivers of Patients With Multiple Sclerosis
A recruiting clinical trial in Istanbul is examining caregiver burden in caregivers of patients with multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS). [EARLY_Phase 1]
An open-label, single-arm early Phase 1 trial evaluating the safety and preliminary efficacy of a CD20 monoclonal antibody combined with NK0…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Palliative Care Model Impact on Knowledge and Attitudes [NA]
This entry reports a registered clinical trial evaluating a palliative care model and its impact on knowledge and attitudes in individuals w…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: An Open-label Study of AZD0120 in Adults With Multiple Sclerosis [Phase 1]
This is an open-label Phase 1 clinical trial of AZD0120 in adults with Multiple Sclerosis. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality? [NA]
A multicenter prospective study protocol in multiple sclerosis evaluating the occurrence of relapses without radiological evidence to determ…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis) [NA]
A clinical trial sponsored by Artvin Coruh University is currently recruiting to assess fatigue and mental well-being in individuals with Mu…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis [Phase 1]
This clinical trial update outlines a Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and pharmacodynamics of P-CD19C…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Pathological Basis of MRI Signal Changes in Multiple Sclerosis
NINDS-sponsored clinical study investigating the pathological basis of MRI signal changes in multiple sclerosis; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis [Phase 3]
Sanofi is conducting a Phase 3 non-inferiority trial comparing subcutaneous Frexalimab to intravenous administration in adults with multiple…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases [Phase 1]
A Phase 1 trial evaluating the safety and preliminary efficacy of KITE-363 in relapsed/refractory autoimmune neurologic diseases is currentl…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Remote Therapeutic Monitoring Exercise Tracking [NA]
This update notes a remote therapeutic monitoring and exercise-tracking clinical trial focused on Parkinson disease and multiple sclerosis. …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity [NA]
This entry reports an active but non-recruiting clinical trial from Hunter College investigating an immersive three-dimensional learning act…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
This clinical trial update announces an ongoing MRI-based study to evaluate activity in multiple sclerosis, sponsored by NINDS, currently re…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis [NA]
This clinical trial update reports on a study investigating autonomic nervous system involvement in multiple sclerosis. The trial is current…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS
This clinical trial update from Ondokuz Mayıs University investigates serum biomarkers GFAP, NfL, and VEGF and their relation to clinical pr…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Improving Cognitive Recovery in Multiple Sclerosis [NA]
King's College London is conducting a clinical trial to improve cognitive recovery in people with multiple sclerosis. The study is currently…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis [Phase 4]
This clinical trial update concerns ocrelizumab discontinuation in relapsing multiple sclerosis, with a Phase 4 study currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis [NA]
This clinical trial update indicates a confirmatory trial is recruiting to evaluate therapies for alleviating fatigue in people with multipl…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.
A clinical trial protocol led by Assistance Publique - Hôpitaux de Paris to develop a leading-edge interdisciplinary care model for people w…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: VR-based Dexterity Training in MS [NA]
A clinical trial evaluating a virtual reality-based dexterity training program for people with Multiple Sclerosis. The study is currently no…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Turkish Version of the Neurogenic Bladder Symptom Score Short Form
Clinical trial update describing the Turkish version of the Neurogenic Bladder Symptom Score Short Form, sponsored by Gaziantep Islam Scienc…